Patients Show Decreased Preference for AI-Generated Messages When Aware of Technology Use
March 11, 2025 - 22:56
In a recent survey conducted by researchers at Duke Health, it was revealed that patients initially favored messages crafted by artificial intelligence (AI) over those written by human clinicians. However, this preference significantly declined when patients were informed that AI technology was involved in generating the messages.
The survey highlighted a complex relationship between patients and AI in healthcare communication. While many patients appreciated the efficiency and clarity of AI-generated messages, their trust diminished upon learning about the technology's involvement. This finding underscores the importance of transparency in healthcare interactions, as patients may feel more comfortable and connected to human-generated responses.
As healthcare continues to integrate advanced technologies, understanding patient perceptions and preferences will be crucial. The study suggests that while AI can enhance communication, it is essential to consider how the knowledge of AI's role may influence patient trust and engagement in their care.
MORE NEWS
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...